Answers are grounded in this paper and cite their sources.
Although percutaneous LVAD provides superior haemodynamic support in patients with cardiogenic shock compared with IABP, the use of these more powerful devices did not improve early survival. These results do not yet support percutaneous LVAD as first-choice approach in the mechanical management of cardiogenic shock.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: